[Results in diabetic therapy with Silubin retard. 3].
D000293:Adolescent; D000328:Adult; D001645:Biguanides / Q000627:therapeutic use*; D002784:Cholesterol / Q000378:metabolism; D003692:Delayed-Action Preparations; D003920:Diabetes Mellitus / Q000188:drug therapy*; D003927:Diet, Diabetic; D004357:Drug Synergism; D005260:Female; D005951:Glucose Tolerance Test; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D007328:Insulin / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D009765:Obesity; D011379:Prognosis
D001645:Biguanides; D003692:Delayed-Action Preparations; D007004:Hypoglycemic Agents; D007328:Insulin; D002784:Cholesterol
Ergebnisse der Diabetestherapie mit Silubin retard. 3.